The global antidiabetics market is witnessing substantial growth due to the increasing prevalence of diabetes, growing awareness regarding disease management, and continuous advancements in pharmaceutical therapies. Diabetes has emerged as one of the most significant public health challenges worldwide, creating a strong demand for effective treatment solutions that help manage blood glucose...

According to a new report from Intel Market Research, the global diabetes drugs market was valued at USD 99,880 million in 2024 and is projected to grow from USD 108,000 million in 2025 to USD 218,800 million by 2032, exhibiting a robust CAGR of 12.1% during the forecast period (2025–2032). This growth is driven by the rising global prevalence of diabetes, increased healthcare...